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Introduction
The BSR Biologics Register demonstrates increased risk
of serious soft tissue infections in anti-TNFa managed
patients. Mobility levels may increase with successful
symptom management. However patients’ feet present
with a combination of foot deformity and compromised
tissue viability, with associated risk of ulceration and
concomitant infection.
Case presentation
A 50 year old male with AS presented with foot ulcera-
tion and cellulitis, following Infliximab administration.
Management involved multiple antibiotics for recurrent
infections and weekly podiatric care. Infliximab was
stopped, leading to a flare of his arthritis and deteriorat-
ing gait and posture, complicating wound management.
Active inflammation contributed to impaired wound
healing.
After 8 months the patient remains off therapy.
Although the chronic ulcer is improving, frequent
wound / foot care is required. MRI and X-rays have
been used to monitor for bone and joint sepsis.
Discussion
This case demonstrates the impact of anti–TNFa in the
presence of a foot wound. Multiple complications occur
from the presence of infection and drug withdrawal.
Rest increases joint stiffness and pain. It can be difficult
to distinguish between infection & disease related
inflammation. Drug benefits make patients reluctant to
report foot problems, although in this case it was patient
lack of understanding.
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